1 IF D H HT T 100 - 100 1 i T 1 Pgiam/iStock via Getty Images Investment update In February 2023, I rated United Therapeutics Corporation (NASDAQ:UTHR) a buy here on Seeking Alpha and bought large quantities of UTHR stock for our longbiased portfolios here at Bernard. I rehashed the thesis two more times, in May '23, and the most recent in August. That publication, titled "eyeing a re-rating to 12-13x P/E, growth more than justified", detailed several bullish points to consider on UTHR. These all remain in ...